Richard R. DeLuca, Executive Vice President & President, Merck Animal Health, on August 06, 2026, sold 6,050 shares in Merck & Co. (MRK) for $788,773. Following the Form 4 filing with the SEC, DeLuca has control over a total of 155,487 common shares of the company, with 155,487 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/310158/000031015826000217/xslF345X05/form4.xml
Kendra D Miller, Executive Vice President & General Counsel, on August 06, 2026, sold 13,195 shares in BJ's Restaurants (BJRI) for $916,005. Following the Form 4 filing with the SEC, Miller has control over a total of 25,621 common shares of the company, with 25,621 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1013488/000119312526340569/xslF345X05/ownership.xml
Shawn Tabak, CFO, on August 05, 2026, sold 25,000 shares in Porch Group (PRCH) for $405,158. Following the Form 4 filing with the SEC, Tabak has control over a total of 215,495 common shares of the company, with 215,495 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1784535/000195432726000046/xslF345X05/wk-form4_1786138202.xml
Lisa P. Britt, Senior Vice President and Chief Human Resources Officer, on August 06, 2026, sold 5,850 shares in Thermo Fisher Scientific (TMO) for $3,393,000. Following the Form 4 filing with the SEC, Britt has control over a total of 14,784 common shares of the company, with 14,784 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/97745/000009774526000146/xslF345X05/wk-form4_1786138346.xml